Hematin
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H561572

CAS#: 15489-90-4

Description: Hematin is an iron-containing porphyrin used for testing in vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.


Chemical Structure

img
Hematin
CAS# 15489-90-4

Theoretical Analysis

Hodoodo Cat#: H561572
Name: Hematin
CAS#: 15489-90-4
Chemical Formula: C34H33FeN4O5
Exact Mass: 633.18
Molecular Weight: 633.500
Elemental Analysis: C, 64.46; H, 5.25; Fe, 8.82; N, 8.84; O, 12.63

Price and Availability

Size Price Availability Quantity
1g USD 295 2 Weeks
5g USD 650 2 Weeks
10g USD 950 2 Weeks
Bulk inquiry

Synonym: Hematin; Ferrihemate; Ferriheme; Ferriheme hydroxide; Ferrihemic acid

IUPAC/Chemical Name: 3-[18-(2-Carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid iron(2+) hydroxide

InChi Key: BMUDPLZKKRQECS-HXFTUNQESA-K

InChi Code: InChI=1S/C34H34N4O4.Fe.H2O/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);;1H2/q;+3;/p-3/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;;

SMILES Code: CC1=C(C=C2C(C)=C(C=C)C3=[N]2[Fe]45(O)N6C(C(C)=C(C=C)C6=C7)=C3)N4C(C=C8[N]5=C7C(C)=C8CCC(O)=O)=C1CCC(O)=O

Appearance: Solid powder

Purity: >90% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 633.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Balwani M, Bloomer J, Desnick R; Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. Erythropoietic Protoporphyria, Autosomal Recessive. 2012 Sep 27 [updated 2017 Sep 7]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from http://www.ncbi.nlm.nih.gov/books/NBK100826/ PubMed PMID: 23016163.

2: Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017 Aug 31;377(9):862-872. doi: 10.1056/NEJMra1608634. Review. PubMed PMID: 28854095.

3: Xiao SH, Sun J. Schistosoma hemozoin and its possible roles. Int J Parasitol. 2017 Mar;47(4):171-183. doi: 10.1016/j.ijpara.2016.10.005. Epub 2016 Dec 22. Review. PubMed PMID: 28012717.

4: Arora S, Young S, Kodali S, Singal AK. Hepatic porphyria: A narrative review. Indian J Gastroenterol. 2016 Nov;35(6):405-418. Epub 2016 Oct 31. Review. PubMed PMID: 27796941.

5: Wildemeersch D, Andrade A, Goldstuck N. Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System-A Review of 10 Years of Clinical Experience. Clin Med Insights Reprod Health. 2016 Aug 9;10:19-27. doi: 10.4137/CMRH.S40087. eCollection 2016. Review. PubMed PMID: 27547046; PubMed Central PMCID: PMC4979586.

6: Thota S, Yerra R. Drug Discovery and Development of Antimalarial Agents: Recent Advances. Curr Protein Pept Sci. 2016;17(3):275-9. Review. PubMed PMID: 26796302.

7: Bissell DM, Wang B. Acute Hepatic Porphyria. J Clin Transl Hepatol. 2015 Mar;3(1):17-26. doi: 10.14218/JCTH.2014.00039. Epub 2015 Mar 15. Review. PubMed PMID: 26357631; PubMed Central PMCID: PMC4542079.

8: Liao H, Liu M, Cheng A. [Structural features and functional mechanism of TonB in some Gram-negative bacteria-A review]. Wei Sheng Wu Xue Bao. 2015 May 4;55(5):529-36. Review. Chinese. PubMed PMID: 26259476.

9: León-Sicairos N, Angulo-Zamudio UA, de la Garza M, Velázquez-Román J, Flores-Villaseñor HM, Canizalez-Román A. Strategies of Vibrio parahaemolyticus to acquire nutritional iron during host colonization. Front Microbiol. 2015 Jul 9;6:702. doi: 10.3389/fmicb.2015.00702. eCollection 2015. Review. PubMed PMID: 26217331; PubMed Central PMCID: PMC4496571.

10: Mahapatra DK, Bharti SK, Asati V. Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives. Eur J Med Chem. 2015 Aug 28;101:496-524. doi: 10.1016/j.ejmech.2015.06.052. Epub 2015 Jul 10. Review. PubMed PMID: 26188621.

11: Bissell DM, Wang B, Lai J. Hereditary Coproporphyria. 2012 Dec 13 [updated 2015 Jul 1]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from http://www.ncbi.nlm.nih.gov/books/NBK114807/ PubMed PMID: 23236641.

12: Yazdanbakhsh K. Mechanisms of sickle cell alloimmunization. Transfus Clin Biol. 2015 Aug;22(3):178-81. doi: 10.1016/j.tracli.2015.05.005. Epub 2015 Jun 6. Review. PubMed PMID: 26056038; PubMed Central PMCID: PMC4806679.

13: Dong C, Zheng H, Huang S, You N, Xu J, Ye X, Zhu Q, Feng Y, You Q, Miao H, Ding D, Lu Y. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis. Exp Cell Res. 2015 Oct 1;337(2):146-59. doi: 10.1016/j.yexcr.2015.04.005. Epub 2015 Apr 13. Review. PubMed PMID: 25882498.

14: Ren J, Wang T, Wang E, Wang J. Versatile G-quadruplex-mediated strategies in label-free biosensors and logic systems. Analyst. 2015 Apr 21;140(8):2556-72. doi: 10.1039/c4an02282c. Epub 2015 Feb 23. Review. PubMed PMID: 25705973.

15: Matsumoto T. [Analysis of bacterial small-colony variants isolated from clinical specimens]. Rinsho Byori. 2014 Jul;62(7):727-31. Review. Japanese. PubMed PMID: 25669045.

16: Nakayama K. Porphyromonas gingivalis and related bacteria: from colonial pigmentation to the type IX secretion system and gliding motility. J Periodontal Res. 2015 Feb;50(1):1-8. doi: 10.1111/jre.12255. Epub 2014 Dec 27. Review. PubMed PMID: 25546073; PubMed Central PMCID: PMC4674972.

17: Qiu J, Cheng J, Wang Q, Hua J. Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis. Med Sci Monit. 2014 Sep 23;20:1700-13. doi: 10.12659/MSM.892126. Review. PubMed PMID: 25245843; PubMed Central PMCID: PMC4181308.

18: Muñoz-Sánchez J, Chánez-Cárdenas ME. A review on hemeoxygenase-2: focus on cellular protection and oxygen response. Oxid Med Cell Longev. 2014;2014:604981. doi: 10.1155/2014/604981. Epub 2014 Jul 17. Review. PubMed PMID: 25136403; PubMed Central PMCID: PMC4127239.

19: Jones SR, Bell A, Brink G. Treatment of acute intermittent porphyria in the emergency department. J Emerg Nurs. 2014 May;40(3):257-9; quiz 292-3. doi: 10.1016/j.jen.2013.11.014. Epub 2014 Jan 15. Review. PubMed PMID: 24439243.

20: Tracy JA, Dyck PJ. Porphyria and its neurologic manifestations. Handb Clin Neurol. 2014;120:839-49. doi: 10.1016/B978-0-7020-4087-0.00056-5. Review. PubMed PMID: 24365356.